These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 1554170

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia.
    Gausche M, Persse DE, Sugarman T, Shea SR, Palmer GL, Lewis RJ, Brueske PJ, Mahadevan S, Melio FR, Kuwate JH.
    Ann Emerg Med; 1994 Aug; 24(2):183-9. PubMed ID: 8037382
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist.
    Prystowsky EN, Niazi I, Curtis AB, Wilber DJ, Bahnson T, Ellenbogen K, Dhala A, Bloomfield DM, Gold M, Kadish A, Fogel RI, Gonzalez MD, Belardinelli L, Shreeniwas R, Wolff AA.
    J Am Coll Cardiol; 2003 Sep 17; 42(6):1098-102. PubMed ID: 13678937
    [Abstract] [Full Text] [Related]

  • 11. High-dose adenosine for treatment of refractory paroxysmal supraventricular tachycardia.
    Cheng L, Eilbert W.
    Am J Emerg Med; 2020 Jul 17; 38(7):1541.e3-1541.e4. PubMed ID: 32278568
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of intravenous adenosine in treatment of paroxysmal supraventricular tachycardia in the local population.
    Seet CM.
    Singapore Med J; 1997 Dec 17; 38(12):525-8. PubMed ID: 9550919
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia.
    Ballo P, Bernabò D, Faraguti SA.
    Eur Heart J; 2004 Aug 17; 25(15):1310-7. PubMed ID: 15288158
    [Abstract] [Full Text] [Related]

  • 17. Adenosine-induced atrial arrhythmia: a prospective analysis.
    Strickberger SA, Man KC, Daoud EG, Goyal R, Brinkman K, Knight BP, Weiss R, Bahu M, Morady F.
    Ann Intern Med; 1997 Sep 15; 127(6):417-22. PubMed ID: 9312997
    [Abstract] [Full Text] [Related]

  • 18. Comparing methods of adenosine administration in paroxysmal supraventricular tachycardia: a pilot randomized controlled trial.
    Daengbubpha P, Wittayachamnankul B, Sutham K, Chenthanakij B, Tangsuwanaruk T.
    BMC Cardiovasc Disord; 2022 Jan 26; 22(1):15. PubMed ID: 35081915
    [Abstract] [Full Text] [Related]

  • 19. Accuracy of arrhythmia recognition in paramedic treatment of paroxysmal supraventricular tachycardia: a ten-year review.
    Goebel PJ, Daya MR, Gunnels MD.
    Prehosp Emerg Care; 2004 Jan 26; 8(2):166-70. PubMed ID: 15060851
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.